Tilray Brands (NASDAQ:TLRY) Trading 1.8% Higher – Here’s Why

Tilray Brands, Inc. (NASDAQ:TLRY) shares shot up 1.8% on Wednesday . The stock traded as high as $5.69 and last traded at $5.55. 3,288,637 shares changed hands during trading, a decline of 25% from the average session volume of 4,411,596 shares. The stock had previously closed at $5.45.

Tilray Brands News Summary

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray’s BrewDog brand launched a broad summer “Underdog” marketing campaign in the U.K., including retail promotions, bar activations, digital media, a “Win a Year of Beer” contest, and watch parties, which could help support beverage sales and brand visibility. Article Title
• Positive Sentiment: Tilray Medical highlighted its presence at Cannabis Europa London 2026, reinforcing the company’s international medical-cannabis expertise and its focus on patient access and regulatory discussions. Article Title
• Neutral Sentiment: Several commentary pieces note that Tilray’s fundamentals have improved somewhat, but the stock still hinges heavily on potential U.S. marijuana rescheduling or other federal regulatory changes to drive a sustained move higher. Article Title
• Neutral Sentiment: Another market commentary says Tilray looks positioned for a breakout only if a key catalyst materializes, again emphasizing that regulation rather than operating momentum is likely to matter most for the stock. Article Title
• Negative Sentiment: Recent coverage also stresses that TLRY has fallen sharply this year and remains near multi-month lows, reflecting ongoing investor concern about the company’s weak share performance and limited near-term catalysts. Article Title

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on TLRY. Weiss Ratings cut shares of Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. Roth Mkm raised shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a research note on Thursday, April 2nd. Wall Street Zen raised shares of Tilray Brands from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st. Canaccord Genuity Group began coverage on shares of Tilray Brands in a research note on Tuesday, January 27th. They set a “hold” rating for the company. Finally, Zacks Research raised shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Wednesday, February 11th. Three analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Tilray Brands has an average rating of “Hold” and a consensus target price of $11.50.

Tilray Brands Stock Up 1.8%

The company has a debt-to-equity ratio of 0.19, a current ratio of 2.79 and a quick ratio of 1.66. The firm’s 50 day moving average is $6.28 and its two-hundred day moving average is $8.02. The firm has a market capitalization of $646.85 million, a P/E ratio of -0.41 and a beta of 1.94.

Tilray Brands (NASDAQ:TLRY) last released its earnings results on Wednesday, April 1st. The company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.10). Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. The firm had revenue of $206.73 million during the quarter, compared to the consensus estimate of $201.35 million. During the same period in the prior year, the business posted ($0.87) earnings per share. Research analysts predict that Tilray Brands, Inc. will post -0.58 EPS for the current year.

Insider Buying and Selling at Tilray Brands

In related news, Director David G. Hopkinson sold 33,556 shares of the firm’s stock in a transaction on Tuesday, April 21st. The shares were sold at an average price of $6.94, for a total value of $232,878.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.84% of the company’s stock.

Hedge Funds Weigh In On Tilray Brands

Several hedge funds and other institutional investors have recently made changes to their positions in TLRY. AQR Capital Management LLC grew its stake in shares of Tilray Brands by 1,839.7% in the first quarter. AQR Capital Management LLC now owns 607,054 shares of the company’s stock valued at $399,000 after buying an additional 575,757 shares in the last quarter. XTX Topco Ltd bought a new position in shares of Tilray Brands in the second quarter valued at $112,000. Cerity Partners LLC grew its stake in shares of Tilray Brands by 98.5% in the second quarter. Cerity Partners LLC now owns 92,560 shares of the company’s stock valued at $38,000 after buying an additional 45,929 shares in the last quarter. Ausdal Financial Partners Inc. bought a new position in Tilray Brands during the second quarter worth $939,000. Finally, Bank of America Corp DE boosted its position in Tilray Brands by 26.5% during the second quarter. Bank of America Corp DE now owns 311,810 shares of the company’s stock worth $129,000 after purchasing an additional 65,379 shares during the period. 9.35% of the stock is owned by institutional investors.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.